financetom
Business
financetom
/
Business
/
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
Jul 24, 2024 4:34 AM

07:02 AM EDT, 07/24/2024 (MT Newswires) -- Travel + Leisure ( TNL ) reported Q2 adjusted earnings Wednesday of $1.52 per diluted share, up from $1.33 a year earlier.

Analysts polled by Capital IQ expected $1.41.

Net revenue for the quarter ended on June 30 was $985 million, up from $949 million a year earlier.

Analysts surveyed by Capital IQ expected $987.2 million.

The company expects Q3 adjusted EBITDA of $235 million to $245 million. Analysts polled by Capital IQ expect $238.7 million. The company updated its full-year adjusted EBITDA to a new range of $915 million to $935 million versus the prior outlook of $910 million to $930 million. Analysts polled by Capital IQ expect $921.6 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arcellx Insider Sold Shares Worth $1,355,024, According to a Recent SEC Filing
Arcellx Insider Sold Shares Worth $1,355,024, According to a Recent SEC Filing
Jan 13, 2025
03:22 AM EST, 01/13/2025 (MT Newswires) -- Michelle Gilson, Chief Financial Officer, on January 07, 2025, sold 18,009 shares in Arcellx ( ACLX ) for $1,355,024. Following the Form 4 filing with the SEC, Gilson has control over a total of 9,582 shares of the company, with 9,582 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1786205/000141588925001345/xslF345X05/form4-01112025_020131.xml ...
Bezos' Blue Origin delays New Glenn debut launch
Bezos' Blue Origin delays New Glenn debut launch
Jan 13, 2025
WASHINGTON, Jan 13 (Reuters) - Jeff Bezos' Blue Origin called off the launch of its New Glenn rocket after a few anomalies during the mission countdown on Monday, postponing by at least a day an inaugural attempt to reach orbit and compete with SpaceX in the satellite launch market. ...
GSK to Acquire Oncology Firm IDRx for Up to $1.15 Billion
GSK to Acquire Oncology Firm IDRx for Up to $1.15 Billion
Jan 13, 2025
03:21 AM EST, 01/13/2025 (MT Newswires) -- GSK (GSK) has agreed to acquire oncology company IDRx for up to $1.15 billion, the companies said Monday. The consideration includes $1 billion in an upfront payment, and up to $150 million in potential regulatory-based milestone payments. GSK will also be responsible for milestone and royalty payments owed to Merck KGaA related to...
Arcellx Insider Sold Shares Worth $2,263,942, According to a Recent SEC Filing
Arcellx Insider Sold Shares Worth $2,263,942, According to a Recent SEC Filing
Jan 13, 2025
03:22 AM EST, 01/13/2025 (MT Newswires) -- Rami Elghandour, Director, President, Chief Executive Officer and Chairman of the Board, on January 07, 2025, sold 30,311 shares in Arcellx ( ACLX ) for $2,263,942. Following the Form 4 filing with the SEC, Elghandour has control over a total of 117,275 shares of the company, with 117,275 shares held directly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved